Treating psychological conditions using muscarinic receptor M1 antagonists
US7893053B2 · kind B2 · utility
0Cited by
16References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 14, 2007 |
| Grant date | Feb 22, 2011 |
| Priority date | — |
| Expiry date | Jun 9, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are methods of treating psychological diseases and conditions by administration of a preferential muscarinic acetylcholine receptor M1 antagonist, optionally with at least one antidepressant other than a selective muscarinic acetylcholine receptor M1 antagonist. The invention also provides for pharmaceutical compositions and kits for administration of at least one selective muscarinic acetylcholine receptor M1 antagonist in combination with at least one antidepressant other than a selective muscarinic acetylcholine receptor M1 antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.